Antidiabetic potential of a long-acting derivative of GIP following once daily administration in type 2 diabetes.

Research output: Contribution to journal › Meeting abstract › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{735fd730ecbb4e47b5849e3a721fef0d,

title = "Antidiabetic potential of a long-acting derivative of GIP following once daily administration in type 2 diabetes.",

author = "V.A. Gault and N. Irwin and F.P.M. O'Harte and Brian Green and P.R. Flatt",

year = "2004",

language = "English",

volume = "122",

pages = "P20",

journal = "Regulatory Peptides",

issn = "0167-0115",

publisher = "Elsevier B.V.",

}